Sign in
Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir
Journal article   Open access  Peer reviewed

Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir

Perry H. Dubin, Seth N. Sclair, Rene Rico, Amelia K. Boehme, Emerson Y. Chen, Paul Martin and William M. Lee
Digestive diseases and sciences, Vol.60(1), pp.272-274
2015-01-01
PMCID: PMC4604568
PMID: 25283376

Abstract

Gastroenterology & Hepatology Life Sciences & Biomedicine Science & Technology
url
https://doi.org/10.1007/s10620-014-3374-1View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.125 Hepatitis
1.125.83 HCV
Web Of Science research areas
Gastroenterology & Hepatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details